Quality of evidence: C -
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Authors: Fang et al
Journal: The Lancet
Objectives: Assess the link between diabetes and hypertension treatments and the risk of contamination in patients with COVID-19
Strength of evidence: Low (short correspondence, hypothesis-driven, no methodology, not a systematic review)
Methods/publication type: Correspondance, short letter, hypothesis=driven review
Highlights :
Patients with heart disease, hypertension or diabetes and treated with ACE inhibitors or ARA2 may be at more severe risk during COVID-19
Special need for close monitoring in these patients
Possible alternatives to current treatments: calcium channel blocker/antagonists
Comments